Home  »  Companies   »  Ventyx Biosciences Inc. (NASDAQ: VTYX) Is Up 6.34%...

Ventyx Biosciences Inc. (NASDAQ: VTYX) Is Up 6.34% Year-To-Date, Analysts Forecast Major Price Rally

Ventyx Biosciences Inc. (NASDAQ:VTYX) traded at $34.87 at close of the session on Monday, 01/23/23, made an upward move of 2.11% on its previous day’s price.

Looking at the stock we see that its previous close was $34.15 with the day’s price range being $33.3689 – $36.69. In terms of its 52-week price range, VTYX has a high of $41.29 and a low of $9.50. The company’s stock has gained about 10.45% over that past 30 days.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

Ventyx Biosciences Inc. has a market cap of $1.96 billion and is expected to release its quarterly earnings report on Nov 03, 2022. Estimates by analysts give the company expected earnings per share (EPS) of -$0.44, with the EPS growth for the year raised at -$1.79 for 2022 and -$2.17 for next year. These figures represent 73.10% and -21.20% growth in EPS for the two years respectively.

There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the VTYX stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of 50% Buy. Long term indicators on average place the stock in the category of 100% Buy.

Based on estimates by 11 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the Ventyx Biosciences Inc. (VTYX) stock as a Hold, while 11 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.

Looking further, we note the current price level is 7.06% off its SMA20 and 16.61% from its 50-day simple moving average. The RSI (14) is pointing at 60.84 while the volatility over the past week is 6.60% and jumps to 6.53% over the past one month. The average price target for the stock over the next 12 months is $51.45, with the estimates having a low of $35.00 and a high of $63.00. These price ends are -0.37% and -80.67% off the current price level respectively, although investors could be excited at the prospect of a -43.39% if the VTYX share price touches on the median price of $50.00.

Let’s briefly compare Ventyx Biosciences Inc. (VTYX) stock to its peers. We find that current price change of 2.11% and 141.48% over the past 12 months for VTYX competes that of Johnson & Johnson (JNJ), which has seen its stock price fall -0.25% in the last trading session and was 1.85% over the last one year. Another of its peers Eli Lilly and Company (LLY) has dropped -1.12% previous session, and was 40.75% up over the past year, while AbbVie Inc. (ABBV) was also down -0.70% in the last session, while its price remained in the green at 11.67% over the same period. In contrast to these companies, both the S&P 500 Index and the Dow Jones Industrial were at 1.19% and 0.76%, respectively, at close of the trading.

Coming back to Ventyx Biosciences Inc. (NASDAQ:VTYX), we note that the average 3-month trading volume was 583.92K, while that of the preceding 10-day period stands at 0.4 million. Current shares outstanding are 51.67 million.

The insiders hold 3.80% of the company’s shares while institutions hold 99.70%. The data shows that short shares as of Oct 13, 2022, stood at 3.99 million at a short ratio of 8.15. This represents a 7.06% short interest in shares outstanding on Oct 13, 2022. Shares short rose in October from the previous month at 3.5 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 6.34% up in year-to-date price movement.

Leave a Comment

Your email address will not be published. Required fields are marked *